WallStreetZenWallStreetZen

NYSEMKT: MYO
Myomo Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MYO

Based on 1 analyst offering 12 month price targets for Myomo Inc

Min Forecast
$10.00+861.54%
Avg Forecast
$10.00+861.54%
Max Forecast
$10.00+861.54%

Should I buy or sell MYO stock?

Based on 1 analyst offering ratings for Myomo Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MYO's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates MYO as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their MYO stock forecasts and price targets.

MYO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-06-08

1 of 1

Forecast return on equity

Is MYO forecast to generate an efficient return?

Company
130.06%
Industry
17.22%
Market
172.65%
MYO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MYO forecast to generate an efficient return on assets?

Company
31.85%
Industry
14.28%
MYO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MYO earnings per share forecast

What is MYO's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.34
Avg 2 year Forecast
-$0.26
Avg 3 year Forecast
-$0.26

MYO revenue forecast

What is MYO's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$44.9M+8.9%
Avg 2 year Forecast
$50.7M+23.08%
Avg 3 year Forecast
$50.7M+23%
MYO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MYO revenue growth forecast

How is MYO forecast to perform vs Medical Devices companies and vs the US market?

Company
7.83%
Industry
8.54%
Market
14.23%
MYO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MYO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MYO vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
MYO$1.04$10.00+861.54%Buy
MOVE$21.71N/AN/A
PAVM$5.94$56.00+842.76%Buy
ELUT$0.98N/AN/A
NSYS$15.82N/AN/A
View Top Medical Device Stocks

Myomo Stock Forecast FAQ

Is Myomo Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSEMKT: MYO) stock is to Buy MYO stock.

Out of 1 analyst, 0 (0%) are recommending MYO as a Strong Buy, 1 (100%) are recommending MYO as a Buy, 0 (0%) are recommending MYO as a Hold, 0 (0%) are recommending MYO as a Sell, and 0 (0%) are recommending MYO as a Strong Sell.

If you're new to stock investing, here's how to buy Myomo stock.

What is MYO's earnings growth forecast for 2026-2027?

(NYSEMKT: MYO) Myomo's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 22.77%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.24%.

Myomo's earnings in 2026 is -$15,118,224.On average, 6 Wall Street analysts forecast MYO's earnings for 2026 to be -$13,191,236, with the lowest MYO earnings forecast at -$14,389,034, and the highest MYO earnings forecast at -$12,982,587. On average, 6 Wall Street analysts forecast MYO's earnings for 2027 to be -$9,910,814, with the lowest MYO earnings forecast at -$10,981,105, and the highest MYO earnings forecast at -$8,925,529.

In 2027, MYO is forecast to generate -$9,910,814 in earnings, with the lowest earnings forecast at -$10,981,105 and the highest earnings forecast at -$8,925,529.

What is MYO's revenue growth forecast for 2026-2027?

(NYSEMKT: MYO) Myomo's forecast annual revenue growth rate of 7.83% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.23%.

Myomo's revenue in 2026 is $41,209,517.On average, 6 Wall Street analysts forecast MYO's revenue for 2026 to be $1,734,025,469, with the lowest MYO revenue forecast at $1,616,873,073, and the highest MYO revenue forecast at $1,851,912,000. On average, 6 Wall Street analysts forecast MYO's revenue for 2027 to be $1,959,752,480, with the lowest MYO revenue forecast at $1,711,537,773, and the highest MYO revenue forecast at $2,291,619,871.

In 2027, MYO is forecast to generate $1,958,516,043 in revenue, with the lowest revenue forecast at $1,711,537,773 and the highest revenue forecast at $2,224,775,001.

What is MYO's forecast return on assets (ROA) for 2026-2029?

(NYSEMKT: MYO) forecast ROA is 31.85%, which is higher than the forecast US Medical Devices industry average of 14.28%.

What is MYO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MYO price target, the average MYO price target is $10.00, with the highest MYO stock price forecast at $10.00 and the lowest MYO stock price forecast at $10.00.

The Wall Street analyst predicted that Myomo's share price could reach $10.00 by Jun 8, 2027. The average Myomo stock price prediction forecasts a potential upside of 861.54% from the current MYO share price of $1.04.

What is MYO's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSEMKT: MYO) Myomo's current Earnings Per Share (EPS) is -$0.36. On average, analysts forecast that MYO's EPS will be -$0.34 for 2026, with the lowest EPS forecast at -$0.37, and the highest EPS forecast at -$0.34. On average, analysts forecast that MYO's EPS will be -$0.26 for 2027, with the lowest EPS forecast at -$0.28, and the highest EPS forecast at -$0.23. In 2027, MYO's EPS is forecast to hit -$0.26 (min: -$0.28, max: -$0.23).

What is MYO's forecast return on equity (ROE) for 2026-2029?

(NYSEMKT: MYO) forecast ROE is 130.06%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.